D
Haleon plc HLN
$9.36 -$0.535-5.41%
Recommendation
Sell
Prev Close
$9.89
Volume
7,254,704
Avg Vol (90D)
9,329,116
Market Cap
$44.79B
Dividend & Yield
$0.158(1.60%)
52-Week Range
$7.99 - $10.80
P/E (TTM)
134.38
EPS (TTM)
$0.0736
My Lists My Alerts
Rating
Reward
C-
Fair
Risk
D+
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Fair
Solvency Index
Good
Total Return Index
Fair
Volatility Index
Fair
Dividend Index
Fair
Headlines
Haleon (NYSE:HLN) Shares Gap Up - Here's Why
4/5/2025 - MarketBeat
Haleon (LON:HLN) Sets New 52-Week High - Here's What Happened
4/5/2025 - MarketBeat
Haleon plc (NYSE:HLN) Holdings Lifted by Pitcairn Co.
4/5/2025 - MarketBeat
American Century Companies Inc. Buys 41,189 Shares of Haleon plc (NYSE:HLN)
4/5/2025 - MarketBeat
Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure
4/4/2025 - Zacks Investment Research
Haleon PLC Executes Share Buyback to Strengthen Market Position
4/4/2025 - TipRanks Financial Blog
Wellington Management Group LLP Boosts Holdings in Haleon plc (NYSE:HLN)
4/4/2025 - Ticker Report
Haleon (NYSE:HLN) Shares Gap Up - What's Next?
4/3/2025 - Ticker Report
Haleon PLC Executes Share Buyback Programme
4/3/2025 - TipRanks Financial Blog
Haleon plc (NYSE:HLN) Given Consensus Recommendation of "Hold" by Analysts
4/1/2025 - Ticker Report
Clearbridge Investments LLC Has $312.94 Million Holdings in Haleon plc (NYSE:HLN)
3/31/2025 - MarketBeat
Quantbot Technologies LP Purchases Shares of 66,443 Haleon plc (NYSE:HLN)
3/28/2025 - MarketBeat
Haleon plc (NYSE:HLN) Receives Consensus Rating of "Hold" from Brokerages
3/27/2025 - MarketBeat
Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off
3/25/2025 - Seeking Alpha - Long Ideas
Haleon: A Defensive Play That Makes Sense Amidst The Stock Market Sell-Off
3/25/2025 - SeekingAlpha
Haleon (LON:HLN) Shares Down 1.9% - Should You Sell?
3/25/2025 - MarketBeat
Is magic suddenly happening to the dirt cheap GSK share price?
3/23/2025 - The Motley Fool UK
Kepler Capital Reaffirms Their Buy Rating on Haleon PLC (HLN)
3/22/2025 - TipRanks Financial Blog
Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals
3/21/2025 - Zacks Investment Research
Haleon PLC Announces Executive Share Awards to Strengthen Leadership
3/21/2025 - TipRanks Financial Blog
Haleon PLC Sees Increase in Major Holdings by Wellington Management
3/20/2025 - TipRanks Financial Blog
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?
3/20/2025 - Zacks Investment Research
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B
3/20/2025 - Zacks Investment Research
Natixis Advisors LLC Grows Stock Holdings in Haleon plc (NYSE:HLN)
3/20/2025 - MarketBeat
Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake
3/19/2025 - Money Mail Online
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$42.96B
Total Debt (Q)
$12.88B
Total Liabilities (Q)
$22.65B
Book Value Per Share (Q)
$2.24
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.24
7-Day Total Return
-7.61%
30-Day Total Return
-7.88%
60-Day Total Return
-1.48%
90-Day Total Return
-3.11%
Year to Date Total Return
-0.95%
1-Year Total Return
13.40%
2-Year Total Return
10.86%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 12, 2024 - $7.99
52-week High
Sep 27, 2024 - $10.80
Valuation
Market Cap
$44.79B - Large Cap
Enterprise Value
$55.15B
Price/Sales (TTM)
12.90
Price/Book (Q)
4.42
Dividends and Shares
Shares Outstanding
9.18B
Dividend Per Share (Most Recent)
$0.0527
Dividend Per Share (TTM)
$0.158
Corporate Info
Website
www.haleon.com
Phone Number
44 1932 959 500
Address
The Heights
Weybridge, KT13 0NY
Country
United Kingdom
Year Founded
1715
Business Description
Sector
--
Industry
--
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa... more
NYSE 04/07/2025 10:48AM Eastern Quotes delayed
Weiss Ratings